Trifecta Capital Advisors, LLC Dexcom Inc Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 18 shares of DXCM stock, worth $1,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 18
-0.0%
Holding current value
$1,354
Previous $2.04 Million
40.86%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,015Shares Held
352MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.57 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.6 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.35 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.25 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.13 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $29.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...